The FDA finds that a heart stent developed by Stryker (SYK) might not be worth the additional...

This news story has 1 comment:

Register or Login to rate comments »

Koshien Kid Comments (118)
 
The FDA's job is to determine whether or not a device or a compound is safe for patients. Its job is most emphatically NOT to assess the cost-benefit relationship for a particular treatment; that is up to the patient and his or her physician, subject to whatever constraints are imposed by the patient's ability to fund the treatment.
This smells like a very sneaky effort on the part of the current administration to squeeze rationing into their PPACA scheme.
21 Mar 2012, 09:13 AM Reply Like